Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 2598
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49200
How many insurance companies are going to pay for
(3)
Drano
09/24/2018 9:38:30 AM
49199
That's why we have the tag team last night and
(4)
Drano
09/24/2018 9:36:48 AM
49198
Funny this fluff business. I have not been able
(1)
RusticBum
09/24/2018 9:35:48 AM
49197
Well they do, BP needs to make sure that their
(3)
zdubble17
09/24/2018 9:35:44 AM
49196
Over the last 5 years my two largest holdings:
(1)
NickAidenNY
09/24/2018 9:27:04 AM
49195
That PR tells me that Leo is extremely confident
(2)
smokenhot
09/24/2018 9:23:56 AM
49194
Love the management comments and sure sounds like
(2)
AlanC
09/24/2018 9:22:45 AM
49193
Funny that the multi ID's talk about trial
(3)
Kelt
09/24/2018 9:14:20 AM
49192
Thanks. My youth came flashing back; the times
(1)
RusticBum
09/24/2018 8:54:31 AM
49191
Looking forward to see what October
bejamin
09/24/2018 8:48:14 AM
49190
Where did I say that IV drug works better? As
(1)
RusticBum
09/24/2018 8:47:52 AM
49189
Not a real big fan of this PR. If there is a
(2)
bejamin
09/24/2018 8:47:24 AM
49188
Excellent article showing why B-OM the leader of
(2)
petemantx
09/24/2018 8:37:30 AM
49187
What concern would a BP have with what IPIX is
(1)
petemantx
09/24/2018 8:29:11 AM
49186
Alan saw your post after I posted. Nice to see!
4kids
09/24/2018 8:11:45 AM
49185
News alert per Fidelity. Traveling so maybe
4kids
09/24/2018 8:04:19 AM
49184
Innovation Pharmaceuticals Provides a Comparative
(1)
AlanC
09/24/2018 7:43:26 AM
49183
If Leo doesn't have a deal done in October and
bejamin
09/24/2018 7:37:11 AM
49182
To finish, I think were buying time till 1st
(3)
Trading Pro Broker
09/24/2018 7:36:05 AM
49181
Good reminder to folks on the value of B-OM. A
Trading Pro Broker
09/24/2018 7:33:06 AM
49180
Very good discussion you started, like to see
bejamin
09/24/2018 7:31:39 AM
49179
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
09/24/2018 7:23:44 AM
49178
I know I'm not a fan of those who attempt to
(1)
BooDog
09/24/2018 7:23:39 AM
49177
and a PR on OM
smokenhot
09/24/2018 7:16:38 AM
49176
New B-OM comparison Blog
(2)
smokenhot
09/24/2018 7:02:28 AM
49175
IMO A big Pharma is doing due diligence and found
zdubble17
09/23/2018 11:08:54 PM
49174
I agree...but Im not concerned. If money were
Commando911
09/23/2018 10:25:10 PM
49173
No, it's not medical semantics. You're making a
(5)
Drano
09/23/2018 8:35:45 PM
49172
I think I love you!!! Kelt
Kelt
09/23/2018 8:33:16 PM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
Newer
Older
Recent Articles
Discovery Silver Secures US$250 Million Credit Facility for Growth
Celestica's Upcoming Financial Results and Investor Day Preview
Plymouth Industrial REIT Announces Q3 Dividend for Shareholders
Alterity Therapeutics Shines at American Neurological Meeting
Alibaba's AI Innovations Boost Stock Markets Significantly
Analyst Downgrades for Key Stocks: Insights and Predictions
Broadcom Inc Analysts Forecast Growth and Market Potential
Top Consumer Stocks to Watch Amid Market Volatility
Innovative Competition to Boost Home Diagnostics with $10 Million
Revolutionizing Network Management with Teleste's New WebUI
MMP Capital Enhances Financing Terms Through Key Partnership
MY DR NOW Expands with New Clinic in Queen Creek, Arizona
Asante Gold Corporation Reports Positive Growth Trends
NFI's Alexander Dennis Commits to Scottish Bus Manufacturing
Celebrating Leadership Excellence: Concorde's Danielle Delongchamp
Flagship Communities REIT Declares Cash Distribution for Unitholders
FitVille Partners with Leading Podiatrists to Innovate Footwear
Bionano Genomics Unveils New CPT Code Enhancing Genetic Testing
Class Action Lawsuit Filed Against Sable Offshore Corp. SOC
Harrow Unveils Exciting Details for Upcoming Investor Day
Graphite One Plans Extension of Share Purchase Warrants
First Nordic and Mawson Join Forces to Expand Gold Exploration
Lantheus Holdings Faces Class Action Over Securities Fraud Claims
CollPlant's Vergenix STR Product Distribution Grows in Europe
C3.ai, Inc. Class Action Lawsuit Update and Insights
B2Gold Mines Operational Insights and Adjusted Production Targets
AerCap Cargo Launches Boeing 777-300ERSF with Kalitta Air
Snap Inc. Faces Securities Fraud Lawsuit: Important Details
LifeMD, Inc. Faces Securities Class Action Lawsuit from Investors
Mobix Labs Launches Hostile Tender Offer for Peraso Stake
Multiplier Celebrated for Global Rebrand by Fast Company Awards
Novo Nordisk Faces Class Action Lawsuit Over Securities Fraud
URAC Launches Revolutionary AI Accreditation for Health Care
Evergold Corp. Announces Key AGM Results and Share Consolidation
Everon Expands Market Presence with New Acquisition Strategy
Avanos Medical Enhances Care with Nexus Medical Acquisition
Immersive Wisdom Secures Renewal from Key U.S. Operations Partner
Exciting Collaboration: Popeyes® Teams with Hot Ones™ for Spicy Menu
Butterball Reports Growing Thanksgiving Celebration Trends
Atavistik Bio Welcomes Dr. Susan Pandya as New CMO
Creator Television®'s Exciting Programming for Hispanic Heritage
Top Analyst Stock Picks to Watch This Week for Growth Potential
Celebrating Groundbreaking Research in AML at the Annual Summit
Trump's Call for Foreign Training Sparks Controversy with South Korea
MBMI Steel Buildings Unveils Innovative Strip Mall Project
Immersive Wisdom Achieves Major Communication Milestone
Cognia Highlights Exceptional Educational Institutions for 2025
Everon Boosts B2B Presence with Strategic Acquisition from ADT
Sunsred Revolutionizes Wellness with Custom Red Light Therapy
Celebrating Recognition of Greenstein & Pittari, LLP Attorneys